Back to search
HFrEF - Heart Failure With Reduced Ejection Fraction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which HFrEF - Heart Failure With Reduced Ejection Fraction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which HFrEF - Heart Failure With Reduced Ejection Fraction trials you may qualify forThe purpose of this study is to determine whether people with CHF, who often have different gut bacteria from healthy, would benefit from replacing their gut ba…
Heart failure (HF) affects more than 6 million adults in the U.S. alone, with increasing prevalence. Cardiovascular congestion with resultant limitation in phys…
The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospita…
DigiCare-HFrEF is an investigator-initiated, multicentre, randomised, open-label, endpoint-blinded, superiority trial designed to evaluate whether a structured…
This is an observational study in which only data are collected from participants receiving their usual treatment. The study is done in people with chronic hear…
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at two different doses in participants with chronic stable hea…
The main purpose of this study is to observe outcomes of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in heart failure (HF) patients with left ventricula…
This retrospective study will take advantage of an existing EU-funded dataset, the BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT-CHF), w…
This is a randomized, double-blind, placebo-controlled two-part study with a multiple escalating dose phase followed by a cohort expansion phase to assess safet…